Preop Laxatives in Robotic Urologic Surgery
Prostate Cancer, Kidney Cancer, Constipation
About this trial
This is an interventional treatment trial for Prostate Cancer
Eligibility Criteria
Inclusion criteria: -Patients 30 years or older undergoing robotic-assisted laparoscopic radical prostatectomy, transperitoneal radical nephrectomy, or transperitoneal partial nephrectomy Exclusion criteria: Patients under 30 years old Patients with a contraindication to receiving polyethylene glycol or other forms of laxatives People who regularly take Miralax Patients undergoing retroperitoneal radical or partial nephrectomy Patients with severe ulcerative colitis or Crohn's disease Patients with intestinal diversions (colostomy, ileostomy) Patients with prior abdominal or pelvic radiation Patients who will not follow up with UIHC postoperatively Patients who are incarcerated
Sites / Locations
- University of Iowa Hospitals & ClinicsRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control
Intervention
Do not receive polyethylene glycol before surgery
Receive polyethylene glycol before surgery